# the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

> **NCT04521400** · PHASE2 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** High dose Interferon-beta 1a
- **DRUG:** Lopinavir/Ritonavir
- **DRUG:** Low dose Interferon-beta 1a

## Key facts

- **NCT ID:** NCT04521400
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-20
- **Primary completion:** 2020-09-04
- **Final completion:** 2020-09-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04521400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04521400, "the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04521400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*